HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum WFA+ -M2BP levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection.

AbstractBACKGROUND & AIMS:
Accurate evaluation of liver fibrosis is crucial for predicting progression of chronic hepatitis B virus (HBV) infection. We assessed the utility of a novel fibrosis glycobiomarker Wisteria floribunda agglutinin-positive Mac-2-binding protein (WFA+ -M2BP) for evaluating liver fibrosis and disease progression in patients with chronic HBV infection.
METHODS:
We enrolled 774 patients with chronic HBV infection, with or without fibrosis, diagnosed by liver biopsy/FibroScan. Patients who underwent liver biopsy (n = 297) were divided into training (n = 221) and validation (n = 76) groups. Serum WFA+ -M2BP values were measured and compared with FIB-4 index, aspartate aminotransferase (AST)-to-platelet ratio (APRI) and AST-to-alanine aminotransferase ratio (AAR) using receiver-operating characteristic (ROC) analysis.
RESULTS:
Serum WFA+ -M2BP levels increased significantly with fibrosis progression (P < 0.0001). Area under the ROC curve of WFA+ -M2BP for diagnosing significant fibrosis was higher than that of FIB-4 (P = 0.198), APRI (P = 0.017) and AAR (P < 0.001), with sensitivity and specificity in the training set of 60.5% and 79.8% and validation set of 59.5% and 82.1%, respectively. Serum WFA+ -M2BP levels were significantly correlated with FibroScan values (P < 0.0001) and improved the accuracy of FibroScan in assessing significant fibrosis. Changes in WFA+ -M2BP levels were parallel with those in FibroScan values during nucleot(s)ide analogues therapy in patients with chronic HBV infection.
CONCLUSIONS:
WFA+ -M2BP is an accurate serum indicator for assessing early stages of liver fibrosis and may monitor regression of fibrosis during the treatment of chronic HBV infection. WFA+ -M2BP provides a simple and reliable alternative or complementary method to liver biopsy and FibroScan.
AuthorsXia Zou, Ming-Yu Zhu, De-Min Yu, Wei Li, Dong-Hua Zhang, Fei-Jie Lu, Qi-Ming Gong, Feng Liu, Jie-Hong Jiang, Min-Hua Zheng, Atsushi Kuno, Hisashi Narimatsu, Yan Zhang, Xin-Xin Zhang
JournalLiver international : official journal of the International Association for the Study of the Liver (Liver Int) Vol. 37 Issue 1 Pg. 35-44 (01 2017) ISSN: 1478-3231 [Electronic] United States
PMID27300763 (Publication Type: Journal Article, Validation Study)
Copyright© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Chemical References
  • Antigens, Neoplasm
  • Biomarkers
  • Membrane Glycoproteins
  • Plant Lectins
  • Receptors, N-Acetylglucosamine
  • TAA90K protein, human
  • wisteria lectin
Topics
  • Adolescent
  • Adult
  • Aged
  • Antigens, Neoplasm (blood)
  • Biomarkers (blood)
  • China
  • Disease Progression
  • Elasticity Imaging Techniques
  • Female
  • Hepatitis B, Chronic (blood, complications)
  • Humans
  • Linear Models
  • Liver (pathology)
  • Liver Cirrhosis (blood, pathology)
  • Male
  • Membrane Glycoproteins (blood)
  • Middle Aged
  • Plant Lectins
  • ROC Curve
  • Receptors, N-Acetylglucosamine
  • Retrospective Studies
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: